The Association of Beta-Blocker Use to Cognitive Impairment Among Adults with Hypertension or Cardiovascular Diseases in the United States

Overview

Journal Chronic Pain Manag

Publisher Gavin Publishers

Date 2020 Jul 15

PMID 32661512

Citations 3

Authors

Fnu Safarudin

Chibuzo O Iloabuchi

Amit Ladani

Usha Sambamoorthi

Affiliations

Soon will be listed here.

Abstract

Background: Some studies have shown that beta-blocker use is associated with better cognitive impairment. However, these studies did not control for pain. The relationship between pain and cognitive impairment has been exhaustively investigated. The association of beta blockers to cognitive impairment in the presence of chronic pain is still unknown.

Objective: To examine the independent association of beta-blocker use to cognitive impairment among adults with hypertension or Cardiovascular Diseases (CVDs).

Methods: We used a cross-sectional study design. We derived data on 8,279 adults from the 2015 Medical Expenditure Panel Survey (MEPS). Study participants were adults (age > 21 years), with hypertension or CVDs and without intracranial injury, Parkinson, Alzheimer's disease and Related Dementia. Cognitive impairment was measured based on 1) confusion or memory loss; 2) problems making decisions, or 3) supervision for participant's safety. Anti-hypertensive medications were categorized into 1) beta-blockers; 2) other anti-hypertensives; and 3) no antihypertensive medication. We used multivariable survey logistic regressions to examine the association between beta-blockers and cognitive impairment after controlling for biological factors, pain, chronic conditions, socioeconomic status, access to healthcare services, behavioral, socio-cultural and external environmental factors.

Results: Overall, 24.2%, 41.9%, and 33.9% reported using beta-blockers, other antihypertensives, and no antihypertensive medications, respectively; 18.1% participants reported cognitive impairment. After controlling for pain, beta-blocker use was not significantly associated with cognitive impairment (AOR= 1.22, 95%CI= 1.00-1.49). In fully adjusted models, the AOR for beta-blockers use was 1.05 (95%CI = 0.84-1.31).

Conclusion: In this first large cross-sectional study, we found that the use of beta-blockers was not associated with cognitive impairment. Future prospective studies that include pain management and blood pressure control are needed to confirm the findings.

Citing Articles

Cognitive decline and diabetes in the clinical setting.

Varga B, Tilinca M, Marton L, Ionescu C, Szabo M Med Pharm Rep. 2025; 98(1):67-75.

PMID: 39949917 PMC: 11817590. DOI: 10.15386/mpr-2653.

A Correlative Relationship Between Heart Failure and Cognitive Impairment: A Narrative Review.

Park M, Kim E J Korean Med Sci. 2023; 38(39):e334.

PMID: 37821090 PMC: 10562184. DOI: 10.3346/jkms.2023.38.e334.

Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review.

Thong E, Quek E, Loo J, Yun C, Teo Y, Teo Y Biology (Basel). 2023; 12(8).

PMID: 37627038 PMC: 10452707. DOI: 10.3390/biology12081154.

Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders.

Zhang L, Hill S, Guo B, Wu B, Alliey-Rodriguez N, Eum S Prog Neuropsychopharmacol Biol Psychiatry. 2021; 113:110464.

PMID: 34756932 PMC: 8932335. DOI: 10.1016/j.pnpbp.2021.110464.

References

Gelber R, Ross G, Petrovitch H, Masaki K, Launer L, White L . Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study. Neurology. 2013; 81(10):888-95. PMC: 3885214. DOI: 10.1212/WNL.0b013e3182a351d4. View

Palac D, Cornish R, MCDONALD W, Middaugh D, Howieson D, Bagby S . Cognitive function in hypertensives treated with atenolol or propranolol. J Gen Intern Med. 1990; 5(4):310-8. DOI: 10.1007/BF02600398. View

Eslami V, Katz M, White R, Sundermann E, Jiang J, Ezzati A . Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and High-Sensitivity C-Reactive Protein. Gerontology. 2016; 63(1):3-12. PMC: 5154794. DOI: 10.1159/000446651. View

Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F . Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci. 2002; 203-204:147-51. DOI: 10.1016/s0022-510x(02)00281-2. View

Ton T, DeLeire T, May S, Hou N, Tebeka M, Chen E . The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment. Alzheimers Dement. 2016; 13(3):217-224. DOI: 10.1016/j.jalz.2016.08.009. View

Lovden M, Xu W, Wang H . Lifestyle change and the prevention of cognitive decline and dementia: what is the evidence?. Curr Opin Psychiatry. 2013; 26(3):239-43. DOI: 10.1097/YCO.0b013e32835f4135. View

Moriarty O, McGuire B, Finn D . The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011; 93(3):385-404. DOI: 10.1016/j.pneurobio.2011.01.002. View

Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mosch E, Kaduszkiewicz H . AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement. 2013; 10(1):76-83. DOI: 10.1016/j.jalz.2012.09.017. View

Mills K, Obst K, Shen W, Molina S, Zhang H, He H . Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis. Ann Intern Med. 2017; 168(2):110-120. PMC: 5788021. DOI: 10.7326/M17-1805. View

10.

Kramer A, Bherer L, Colcombe S, Dong W, Greenough W . Environmental influences on cognitive and brain plasticity during aging. J Gerontol A Biol Sci Med Sci. 2004; 59(9):M940-57. DOI: 10.1093/gerona/59.9.m940. View

11.

Conn V, Ruppar T, Chase J, Enriquez M, Cooper P . Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis. Curr Hypertens Rep. 2015; 17(12):94. PMC: 5662945. DOI: 10.1007/s11906-015-0606-5. View

12.

Moriarty O, Ruane N, OGorman D, Maharaj C, Mitchell C, Sarma K . Cognitive Impairment in Patients with Chronic Neuropathic or Radicular Pain: An Interaction of Pain and Age. Front Behav Neurosci. 2017; 11:100. PMC: 5468384. DOI: 10.3389/fnbeh.2017.00100. View

13.

Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

14.

Gauthier S, Reisberg B, Zaudig M, Petersen R, Ritchie K, Broich K . Mild cognitive impairment. Lancet. 2006; 367(9518):1262-70. DOI: 10.1016/S0140-6736(06)68542-5. View

15.

Burnier M, Egan B . Adherence in Hypertension. Circ Res. 2019; 124(7):1124-1140. DOI: 10.1161/CIRCRESAHA.118.313220. View

16.

Jessen F, Amariglio R, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G . A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014; 10(6):844-52. PMC: 4317324. DOI: 10.1016/j.jalz.2014.01.001. View

17.

Sachdev P, Lipnicki D, Kochan N, Crawford J, Thalamuthu A, Andrews G . The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration. PLoS One. 2015; 10(11):e0142388. PMC: 4634954. DOI: 10.1371/journal.pone.0142388. View

18.

Mazza S, Frot M, Rey A . A comprehensive literature review of chronic pain and memory. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 87(Pt B):183-192. DOI: 10.1016/j.pnpbp.2017.08.006. View

19.

Moriarty O, Finn D . Cognition and pain. Curr Opin Support Palliat Care. 2014; 8(2):130-6. DOI: 10.1097/SPC.0000000000000054. View

20.

Valdes A, Abhishek A, Muir K, Zhang W, Maciewicz R, Doherty M . Association of Beta-Blocker Use With Less Prevalent Joint Pain and Lower Opioid Requirement in People With Osteoarthritis. Arthritis Care Res (Hoboken). 2016; 69(7):1076-1081. DOI: 10.1002/acr.23091. View